US2020254226A1PendingUtilityA1

Pressure attenuation device

Assignee: SOLACE THERAPEUTICS INCPriority: Feb 7, 2019Filed: Feb 6, 2020Published: Aug 13, 2020
Est. expiryFeb 7, 2039(~12.6 yrs left)· nominal 20-yr term from priority
A61F 2250/0059A61F 2250/0003A61M 25/10A61M 2025/1054A61F 2/042A61M 2205/3331A61M 2210/1085A61M 2205/0216
50
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

An pressure attenuation device for use in a body can include a balloon comprising an outer wall and defining an interior chamber therein. The balloon can be configured to elastically deform up to at least to an internal pressure of 90 cm H2O. A high vapor pressure media having a vapor pressure of between 155 cm-185 cm H2O at 37 degrees Celsius can be positioned within the interior chamber. The balloon can have a minimum wall thickness of between 0.001 inches-0.00175 inches.

Claims

exact text as granted — not AI-modified
1 - 19 . (canceled) 
     
     
         20 . A pressure attenuation device for use in a body, the pressure attenuation device comprising:
 a balloon comprising an outer wall and defining an interior chamber therein, the balloon being configured to elastically deform and increase in volume by at least 50% but less than 190% when an internal pressure within the balloon is increased from 2.5 cm H 2 O to 90 cm H 2 O.   
     
     
         21 . The pressure attenuation device of  claim 20 , wherein the balloon is configured to elastically deform and increase in volume by at least 65% but less than 100% when a pressure within the balloon is increased from 2.5 cm H 2 O to 90 cm H 2 O. 
     
     
         22 . The pressure attenuation device of  claim 20  wherein the balloon is configured to elastically deform and increase in volume by at least 75% but less than 90% when a pressure within the balloon is increased from 2.5 cm H 2 O to 90 cm H 2 O. 
     
     
         23 . The pressure attenuation device of  claim 20 , wherein the balloon is configured to elastically deform and increase in volume by at least 20% but less than 150% when a pressure within the balloon is increased from 2.5 cm H 2 O to 70 cm H 2 O. 
     
     
         24 . The pressure attenuation device of  claim 20 , wherein the balloon is configured to elastically deform and increase in volume by at least 30% but less than 100% when a pressure within the balloon is increased from 2.5 cm H 2 O to 70 cm H 2 O. 
     
     
         25 . The pressure attenuation device of  claim 20 , wherein the balloon is configured to elastically deform and increase in volume by at least 45% but less than 60% when a pressure within the balloon is increased from 2.5 cm H 2 O to 70 cm H 2 O. 
     
     
         26 . The pressure attenuation device of  claim 20 , wherein the balloon is configured to elastically deform and increase in volume by at least 10% but less than 45% when a pressure within the balloon is increased from 2.5 cm H 2 O to 40 cm H 2 O. 
     
     
         27 . The pressure attenuation device of  claim 20 , wherein the balloon is configured to elastically deform and increase in volume by at least 18% but less than 30% when a pressure within the balloon is increased from 2.5 cm H 2 O to 40 cm H 2 O. 
     
     
         28 . The pressure attenuation device of  claim 20 , wherein the balloon is configured to elastically deform and increase in volume by at least 19% but less than 27% when a pressure within the balloon is increased from 2.5 cm H 2 O to 40 cm H 2 O 
     
     
         29 . The pressure attenuation device of  claim 20  comprising a high vapor pressure media having a vapor pressure of between 155 cm H 2 O-185 cm H 2 O at 37 degrees Celsius. 
     
     
         30 . The pressure attenuation device of  claim 20 , comprising a high vapor pressure media having a vapor pressure of between 155 cm H 2 O-165 cm H 2 O at 37 degrees Celsius. 
     
     
         31 . The pressure attenuation device of  claim 29  wherein the high vapor pressure media is positioned within the interior chamber. 
     
     
         32 . The pressure attenuation device of  claim 29 , wherein the high vapor pressure media comprises a PFC. 
     
     
         33 . The pressure attenuation device of  claim 20 , wherein the balloon elastically deforms between internal pressures of 2.5 cm H 2 O to 90 cm H 2 O for at least 15 cycles. 
     
     
         34 . The pressure attenuation device of  claim 20 , wherein the balloon has a natural volume of between 1 and 180 cc. 
     
     
         35 . The pressure attenuation device of  claim 20  wherein the balloon has a minimum wall thickness of between 0.001 inches and 0.00175 inches. 
     
     
         36 . An pressure attenuation device for use in a body, the pressure attenuation device comprising:
 a balloon comprising an outer wall and defining an interior chamber therein; and   a high vapor pressure media;   the balloon being configured to deform elastically at least up to an internal pressure within the chamber of 90 cm H 2 O.   
     
     
         37 . The pressure attenuation device of  claim 36  wherein the balloon elastically deforms between internal pressures of 2.5 cm H 2 O to 90 cm H 2 O for at least 15 cycles, 25 cycles, 50 cycles or 100 cycles. 
     
     
         38 . The pressure attenuation device of  claim 37 , wherein the balloon is configured to deform elastically at least up to an internal pressure within the chamber of 100 cm H 2 O. 
     
     
         39 . The pressure attenuation device of  claim 38  wherein the balloon elastically deforms between internal pressures of 2.5 cm H 2 O to 100 cm H 2 O for at least 15 cycles, 25 cycles, 50 cycles or 100 cycles. 
     
     
         40 . The pressure attenuation device of  claim 39 , wherein the balloon is configured to deform elastically at least up to an internal pressure within the chamber of 120 cm H 2 O. 
     
     
         41 . The pressure attenuation device of  claim 40  wherein the balloon elastically deforms between internal pressures of 2.5 cm H 2 O to 120 cm H 2 O for at least 15 cycles. 
     
     
         42 . The pressure attenuation device of  claim 36 , wherein the balloon has a natural volume of between 1 and 180 cc. 
     
     
         43 . The pressure attenuation device of  claim 36 , wherein the balloon has a minimum wall thickness of between 0.001 inches-and 0.00175 inches. 
     
     
         44 . The pressure attenuation device of  claim 43 , wherein the high vapor pressure media has a vapor pressure of between 155 cm H 2 O-185 cm H 2 O at 37 degrees Celsius. 
     
     
         45 . The pressure attenuation device of  claim 44 , wherein the high vapor pressure media has a vapor pressure of between 155 cm H 2 O-165 cm H 2 O at 37 degrees Celsius. 
     
     
         46 . The pressure attenuation device of  claim 45 , wherein the high vapor pressure media is positioned within the interior chamber. 
     
     
         47 . The pressure attenuation device of  claim 46 , wherein the high vapor pressure media comprises a PFC. 
     
     
         48 . The pressure attenuation device of  claim 47 , wherein the high vapor pressure media comprises a liquid at 37 degrees Celsius. 
     
     
         49 . A method of treating urinary incontinence in a human or animal body comprising implanting a pressure attenuation device comprising a balloon comprising an outer wall and defining an interior chamber therein, the balloon having a minimum wall thickness of between 0.001 inches and 0.00175 inches, the balloon being configured to elastically deform up to at least to an internal pressure of 90 cm H 2 O within a bladder of the human or animal body and inflating the pressure attenuation device while in the bladder. 
     
     
         50 - 51 . (canceled)

Join the waitlist — get patent alerts

Track US2020254226A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.